Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disorders.

Mathew SJ, Coplan JD, Schoepp DD, Smith EL, Rosenblum LA, Gorman JM.

CNS Spectr. 2001 Jul;6(7):555-6, 561-4.

PMID:
15573019
2.

The stress system in the human brain in depression and neurodegeneration.

Swaab DF, Bao AM, Lucassen PJ.

Ageing Res Rev. 2005 May;4(2):141-94. Review.

PMID:
15996533
4.

Limbic and HPA axis function in an animal model of chronic neuropathic pain.

Ulrich-Lai YM, Xie W, Meij JT, Dolgas CM, Yu L, Herman JP.

Physiol Behav. 2006 Jun 15;88(1-2):67-76. Epub 2006 May 2.

PMID:
16647726
5.

Organization and regulation of paraventricular nucleus glutamate signaling systems: N-methyl-D-aspartate receptors.

Ziegler DR, Cullinan WE, Herman JP.

J Comp Neurol. 2005 Mar 28;484(1):43-56.

PMID:
15717303
6.

Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.

Mathew SJ, Price RB, Charney DS.

Am J Med Genet C Semin Med Genet. 2008 May 15;148C(2):89-98. doi: 10.1002/ajmg.c.30172. Review.

PMID:
18412102
7.

Are CRF receptor antagonists potential antidepressants?

O'Brien D, Skelton KH, Owens MJ, Nemeroff CB.

Hum Psychopharmacol. 2001 Jan;16(1):81-87.

PMID:
12404602
8.

The HPA and immune axes in stress: the involvement of the serotonergic system.

Leonard BE.

Eur Psychiatry. 2005 Oct;20 Suppl 3:S302-6. Review.

PMID:
16459240
9.
10.

Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.

Herman JP, Ostrander MM, Mueller NK, Figueiredo H.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1201-13. Epub 2005 Nov 4. Review.

PMID:
16271821
11.

Mood disorders: regulation by metabotropic glutamate receptors.

Pilc A, Chaki S, Nowak G, Witkin JM.

Biochem Pharmacol. 2008 Mar 1;75(5):997-1006. doi: 10.1016/j.bcp.2007.09.021. Epub 2007 Oct 5. Review.

PMID:
18164691
12.
13.

Functional interaction between 5-HT(6) receptors and hypothalamic-pituitary-adrenal axis: cognitive implications.

Marcos B, Aisa B, Ramírez MJ.

Neuropharmacology. 2008 Mar;54(4):708-14. doi: 10.1016/j.neuropharm.2007.11.019. Epub 2007 Dec 8.

PMID:
18206183
14.

Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.

Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP, Shinnick-Gallagher P.

Eur J Neurosci. 2006 Sep;24(6):1733-43.

PMID:
17004937
17.

Chronic treatment with the glutamate receptor antagonist MK-801 alters periodontal disease susceptibility.

Breivik T, Gundersen Y, Osmundsen H, Opstad PK, Fonnum F.

J Periodontal Res. 2005 Feb;40(1):28-35.

PMID:
15613076
18.

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression.

Müller N, Schwarz MJ.

Mol Psychiatry. 2007 Nov;12(11):988-1000. Epub 2007 Apr 24. Review.

PMID:
17457312
19.

Role of brain norepinephrine in the behavioral response to stress.

Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, Ma S, Petre CO.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1214-24. Epub 2005 Oct 13. Review.

PMID:
16226365
20.

Involvement of vasopressin in affective disorders.

Surget A, Belzung C.

Eur J Pharmacol. 2008 Apr 7;583(2-3):340-9. doi: 10.1016/j.ejphar.2007.11.065. Epub 2008 Jan 19. Review.

PMID:
18255056

Supplemental Content

Support Center